Related Experiment Video
Updated: Aug 30, 2025

08:12
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
5.6K
Pattern Recognition of microRNA Expression in Body Fluids Using Nanopore Decoding at Subfemtomolar Concentrations
Nanami Takeuchi1, Moe Hiratani1, Ryuji Kawano1
1Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Tokyo 184-8588, Japan.
JACS Au
|August 29, 2022
Summary
This study introduces a novel nanopore-based DNA computing method for detecting microRNA (miRNA) expression patterns. This technique enables sensitive, label-free detection of specific miRNAs linked to bile duct cancer (BDC) for early diagnosis.
Area of Science:
- Biotechnology
- Molecular Diagnostics
- Nanotechnology
Background:
- MicroRNAs (miRNAs) are crucial biomarkers for cancer diagnosis due to their specific expression patterns.
- Simple and sensitive methods for miRNA detection are needed for early cancer detection.
Purpose of the Study:
- To develop a nanopore-based DNA computing system for detecting specific microRNA expression patterns in bile duct cancer (BDC).
- To achieve label-free and highly sensitive detection of disease-specific miRNAs.
Main Methods:
- Utilized nanopore-based DNA computing technology for miRNA detection.
- Encoded miRNA information from BDC patients into diagnostic DNAs (dgDNAs).
- Decoded dgDNA-miRNA complexes electrically using nanopore analysis.
Main Results:
- Successfully detected miRNA expression patterns from BDC patient plasma using the developed system.
- Achieved label-free detection of specific miRNAs associated with bile duct cancer.
- Demonstrated detection of dgDNA-miRNA complexes at subfemtomolar concentrations, significantly improving sensitivity.
Conclusions:
- Nanopore decoding of dgDNA-encoded miRNA information offers a promising approach for simple and early cancer diagnosis.
- The developed method shows potential for improving diagnostic capabilities for bile duct cancer.
- This technology advances the field of molecular diagnostics for cancer biomarkers.

